The Patent Finder
US

Oral Octreotide Administered in Combination with Other Therapeutic Agents

US 10,682,387 In force
OverviewFamilyAssignmentsSources & methods

Term ends Dec 10, 2035 · Medium confidence

Why Medium: A parent in the chain could not be resolved.

Filed May 7, 2018 as application 15/972,557 · Granted Jun 16, 2020
Base term, 20 years from filing
Today
20 years from filing
2015 2035
Clock starts
Dec 10, 2015
Term ends
Dec 10, 2035
Granted
Jun 16, 2020
base term fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Dec 10, 2015, when application 14/965,318, the earliest non-provisional in its chain, was filed (this one was filed May 7, 2018); a parent in its chain could not be resolved (the next row)Dec 10, 2035High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderDec 10, 2035Medium confidence

This family

US 10,682,387this patent
Dec 2035
Dec 2035
Application 16/868,958Abandoned
not computed
not computed
Application 17/545,729Abandoned
not computed
not computed
Application 17/861,996Abandoned
not computed
not computed
Application 18/170,886Abandoned
not computed
not computed
Application 18/490,985Abandoned
not computed
not computed
Application 18/676,960Pending
not computed
not computed
7 of 8 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Mar 6, 2019
Reel 48515, frame 617
Haviv, Asi; Mamluk, Roni; Gelbaum, DanaChiasma, Inc.Assignment of Assignor's Interest
Apr 14, 2020
Reel 52394, frame 664
Chiasma, Inc.HCR Collateral Management, LLCSecurity Interest
Jan 24, 2022
Reel 58739, frame 949
Chiasma, Inc.Amryt Endo, Inc.Merger
Feb 18, 2022
Reel 59048, frame 944
Amryt Endo, Inc.Ares Capital Corporation, As Administrative AgentSecurity Interest
Mar 31, 2022
Reel 59463, frame 374
HCR Collateral Management, LLCAmryt Endo, Inc. (Formerly Chiasma, Inc.)Release of Security Interest
Apr 13, 2023
Reel 63318, frame 849
Ares Capital Corporation, As Administrative AgentAmryt Pharmaceuticals, Inc.; Amryt Endo, Inc.; Amryt Research Limited; Amryt Genetics LimitedRelease of Security Interest
Apr 13, 2023
reel/frame not recorded
Ares Capital Corporation, As Administrative AgentAmryt Pharmaceuticals, Inc.Release of Security Interest
Apr 13, 2023
reel/frame not recorded
Ares Capital Corporation, As Administrative AgentAmryt Endo, Inc.Release of Security Interest
Apr 13, 2023
reel/frame not recorded
Ares Capital Corporation, As Administrative AgentAmryt Research LimitedRelease of Security Interest
Apr 13, 2023
reel/frame not recorded
Ares Capital Corporation, As Administrative AgentAmryt Genetics LimitedRelease of Security Interest
Jan 7, 2026
Reel 73389, frame 551
Amryt Endo, Inc.; Amyrt Pharmaceuticals Inc.Amryt Pharmaceuticals Inc.Merger and Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited